Author:
Harrington K J,Syrigos K N,Uster P S,Zetter A,Lewanski C R,Gullick W J,Vile R G,Stewart J S W
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Cook JA, Glass J, Lebovics R, Bobo H, Pass H, DeLaney TF, Oldfield EH, Mitchell JB, Glatstein E, Goffman TE (1992) Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumours, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine. Cancer Res 52: 719–725
2. Epstein AH, Lebovics RS, Goffman T, Teague D, Fuetsch ES, Glatstein E, Okunieff P, Cook JA (1994) Treatment of locally advanced cancer of the head and neck with 5′-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labelling and thymidine replacement. J Natl Cancer Inst 86: 1775–1780
3. Fornace Jr AJ, Dobson PP, Kinsella TJ (1990) Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine. Int J Radiat Oncol Biol Phys 18: 873–878
4. Fowler JF, Kinsella TJ (1996) The limiting radiosensitization of tumours by S-phase sensitisers. Br J Cancer 74(Suppl): S294–S298
5. Goffman TE, Dachowski LJ, Bobo H, Oldfield EH, Steinberg SM, Cook J, Mitchell JB, Katz D, Smith R, Glatstein E (1992) Long-term follow-up on National Cancer Institute phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation. J Clin Oncol 10: 264–268
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献